757967-88-7

Basic information

• Product Name: 3-Pyrrolidinol,4-amino-(9CI)
• Synonyms: 3-Pyrrolidinol,4-amino-(9CI);4-aMino-3-Pyrrolidinol;4-AMinopyrrolidin-3-ol
• CAS NO: 757967-88-7
• Molecular Formula: C4H10N2O
• Molecular Weight: 102.135
• Product Categories: VARIOUSAMINE
• Mol File: 757967-88-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-Pyrrolidinol,4-amino-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyrrolidinol,4-amino-(9CI)(757967-88-7)
• EPA Substance Registry System: 3-Pyrrolidinol,4-amino-(9CI)(757967-88-7)

Safety Data

• Hazardous Substances Data: 757967-88-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
3-Pyrrolidinol,4-amino-(9CI) is used as a building block for the synthesis of various pharmaceuticals and agrochemicals. Its role in these industries is crucial for creating new compounds with therapeutic or pesticidal properties, contributing to the development of innovative treatments and products.
Used in Medicinal Chemistry and Drug Design:
In the field of medicinal chemistry, 3-Pyrrolidinol,4-amino-(9CI) is utilized as a key component in the design and synthesis of new drugs. Its unique structure allows for the creation of molecules with specific biological activities, potentially leading to the discovery of novel therapeutic agents.
Used in the Development of New Materials and Chemical Processes:
3-Pyrrolidinol,4-amino-(9CI) also has applications in the development of new materials and chemical processes. Its versatility as a compound makes it a valuable asset in creating advanced materials with specialized properties, as well as in optimizing chemical reactions and processes in various industries.
Used in Biological Activity Research:
Due to its potential biological activities, 3-Pyrrolidinol,4-amino-(9CI) is of interest in the study of its pharmacological properties. Researchers may investigate its interactions with biological systems to uncover new applications in medicine and other fields, further expanding its utility and impact.

Upstream product

• 1202380-97-9 (-)-cis-(3R,4S)-4-amino-1-benzylpyrrolidin-3-ol 
• 819080-07-4 trans 1-benzyl-3-amino-4-hydroxypyrrolidine 
• 945483-36-3 (3S,4S,αS)-N(1)-benzyl-3-hydroxy-4-[N'-benzyl-N'-(α-methylbenzyl)amino]pyrrolidine 
• 1262306-34-2 benzyl (+)-(3S,4R)-3-(benzyloxycarbonylamino)-4-hydroxypyrrolidine-1-carboxylate 
• 945483-44-3 (3R,4S,αS)-N(1)-benzyl-3-hydroxy-4-[N-benzyl-N-(α-methylbenzyl)amino]pyrrolidine 

Relevant articles and documents

FUSED HETEROCYCLIC COMPOUND

The present invention relates to a fused heterocyclic compound having the Formula 1, which is useful as a platelet aggregation inhibitor, a method for preparing the same, and a pharmaceutical composition for inhibiting platelet aggregation comprising the same.

Alkyl 4-chlorobenzoyloxycarbamates as highly effective nitrogen source reagents for the base-free, intermolecular aminohydroxylation reaction

Ethyl-(7), benzyl-(8), tert-butyl-(9), and fluorenylmethyl-4- chlorobenzoyloxycarbamates (10) have been prepared as storable and easy-to-prepare nitrogen sources for use in the intermolecular Sharpless aminohydroxylation reaction and its asymmetric variant. These reagents were found to be effective under base-free reaction conditions. The scope and limitations of these methods have been explored using a variety of alkenes, among which, trans-cinnamates, in particular, proved to be good substrates.

THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS

A series of thieno[2,3-6]pyridine derivatives, attached at the 2-position to a substituted anilino moiety, which are substituted in the 3-position by a carbonyl group linked to a pyrrolidin-1-yl ring which in turn forms part of a heteroatom-containing fus

Asymmetric synthesis of 3,4-anti- and 3,4-syn-substituted aminopyrrolidines via lithium amide conjugate addition

The diastereoselective conjugate addition of homochiral lithium amides to methyl 4-(N-allyl-N-benzylamino)but-2-enoate has been used as the key step in a simple and efficient protocol for the preparation of 3,4-substituted aminopyrrolidines. This protocol provides a complementary and stereoselective route to both anti- and syn-3-amino-4-alkylpyrrolidines as well as anti- and syn-3-hydroxy-4-aminopyrrolidines, in high de and ee via β-amino enolate functionalisation. This methodology has been applied to the synthesis of anti-(3S,4S)- and syn-(3R,4S)-3-methoxy-4-(N-methylamino)pyrrolidine. The Royal Society of Chemistry.

PROCESS FOR PRODUCING NITROGENOUS HETEROCYCLIC COMPOUND

A nitrogenous heterocyclic compound such as 3-aminopyrrolidine derivative is produced by hydrogenolysis of an N-substituted nitrogenous heterocyclic compound with normal pressure hydrogen in a water-based solvent in presence of a catalyst. In the case an optically active 1-substituted-3-aminopyrrrolidine derivative is used as a raw material, an optically active 3-aminopyrrolidine derivative can be obtained as a product practically without racemination.

7-(1-PYRROLIDINYL)-3-QUINOLONE-AND-NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS AND FEED ADDITIVES

7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives, of the formula in which X1 is halogen, X2 is hydrogen, halogen, amino or other radical, R1 is alkyl, cycloalkyl, optionally substituted phenyl or other radical, R2 is hydrogen, alkyl or a dioxolylmethyl radical, R 3 i s A is N, CH, C-halogen, or the like, or forms a bridge with R1, and addition products thereof